This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Life Sciences Product Supply and Operations

It is a tall order for Life Sciences companies to consistently deliver the right combination of products, at the right time, at the right cost. Achieving these goals means simultaneously improving the speed of delivery, increasing the quality of products and lowering costs, leaving little or no room for inefficiency. At the same time, the Life Sciences industry is going through unprecedented change, putting new pressures on supply chain and manufacturing operations organizations. Click here to learn about our practice.

We invite you to view the video below for more information about how we can help transform your business.

Learn more about Life Sciences Product Supply and Operations by clicking on the tabs below:
  • Here's the debate
  • My take
  • Join the conversation

Hot topics

Understand the Emerging Trends
Deloitte fosters an internal learning ecosystem to monitor emerging trends in Life Science Product Supply and Operations. Periodically, our front line practitioners select the “hottest” trends that are shaping the Life Science industry. A selective group of practitioners conduct rigorous research to understand the hot topic’s potential impact to our clients.

Current Hot Topic: 3D Printing & Medical Device Companies
Trend Description:
3D Printing has the potential to transform a manufacturing supply chain. With its ability to manufacture high-quality complex designs in a fully automated process, it reduces the need to manufacture centrally and ship to end users. Additionally, the sourcing of components can potentially be simplified to the raw materials used by the printer.

Impact to our clients: While 3D Printing technology remains largely untested by Medical Device companies, the outlook is that of a potentially transformative impact on supply chains, other aspects of Medical Device companies’ operating models and ultimately how providers delivery high-quality patient care. Our research unveiled three major impact areas to Medical Device Companies:

  1. Financial impacts: e.g. 3D Printing can be utilized to enable a faster response to shifts in demand
  2. Operation model impacts: e.g. Quality & Process Regulation
  3. Supply Chain Redesign and a New Standard of Patient Care: e.g. Integrated Critical Care

To learn more about the 3D printing trends impacts to Medical Device Companies or if you would like to learn about any hot trend? Please contact LifeSciencesSupplyChain@Deloitte.com with your “hottest” trend nominee and stay tuned for our next hot topic summary.

Featured insights

Prescribed behavior: Operating under a consent decree
Read the Pharmaceutical Executive magazine article.
Operating under consent decree
Managing a Life Sciences company through a major regulatory action.
Moving target: Life sciences, health care reform and the new marketplace
Explore the far-reaching impacts of health care reform on the U.S. health industry and marketplace.
Secure supply chain 2015: Building now for tomorrow's risks
Predict and prepare for the future, 2015 and beyond.

Our capabilities

  • Supply chain strategy and excellence (including Tax)
  • Sales and operations planning (S&OP)
  • cGMP/QA/validation compliance
  • Sourcing and procurement
  • Research and development (R&D) supply chain interface
  • Supply chain integrity
  • Manufacturing excellence
  • Logistics and distribution, inclusive of cold chain
  • Environmental health and safety
  • Supply chain and manufacturing information technology (IT)/architecture
  • Competency, talent and organizational design
Based on our capabilities and experience, we have developed a number of market-tested solutions to address issues that are common across Life Science companies and generally require a cross-functional approach:
  • Indirect procurement
  • Non-compliance response
  • Post-merger integration
  • Asset acquisition and divest
  • Supply chain information technology
  • Supply chain integrity
  • Sustainable supply chain
  • Virtual supply chain
  • Med Device / Pharmaceutical manufacturing execution systems
  • Supply chain analytics
  • Corporate supply chain risk

Attachments

 

Our leadership

Sanjay Behl
Principal, Deloitte Consulting LLP

Mini case studies

From Issue to Impact
Deloitte provides a depth and breadth of knowledge and experience in Life Sciences Supply Chain. Learn about how we make an impact for our clients – helping them to tackle many of their challenging and significant problems – by reading about some of our client engagements.

Contact us

To connect with one of our practice leaders, please call us at 615-718-9793 or send an email to LifeSciencesSupplyChain@Deloitte.com.

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Related links

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected